Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Baroreflex sensitivity as a new marker for risk stratification.

M T La Rovere1

  • 1Divisione di Cardiologia, Centro Medico Montescano, Pavia. mtlarovere@fsm.it

Zeitschrift Fur Kardiologie
|May 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinguishable DNA methylation defines a cardiac-specific epigenetic clock.

Clinical epigenetics·2023
Same author

Sodium nitroprusside for advanced heart failure. A metanalysis of literature data.

Vascular pharmacology·2022
Same author

Additional predictive value of nutritional status in the prognostic assessment of heart failure patients.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2016
Same author

Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and France: A Markov Model-Based Cost-Effectiveness Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Clinical value of baroreflex sensitivity.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2012
Same author

Non-invasive baroreflex sensitivity assessment using wavelet transfer function-based time-frequency analysis.

Physiological measurement·2010

Reduced baroreflex sensitivity is a significant risk factor for cardiac death after myocardial infarction. Analyzing autonomic markers, like baroreflex sensitivity, improves risk stratification, especially in younger patients with reduced heart function.

Area of Science:

  • Cardiology
  • Autonomic Neuroscience
  • Clinical Research

Background:

  • The arterial baroreflex regulates autonomic influences on the heart, impacting arrhythmogenesis.
  • Baroreflex sensitivity (BRS) quantifies cardiac autonomic activity, measured via heart rate response to blood pressure changes.
  • Experimental data links lower BRS to increased ventricular fibrillation risk.

Purpose of the Study:

  • To evaluate BRS as a risk factor for cardiac death post-myocardial infarction.
  • To determine if autonomic markers improve cardiovascular risk stratification.
  • To assess the utility of BRS in identifying high-risk patients for sudden cardiac death prevention.

Main Methods:

  • Phenylephrine-induced blood pressure rise to measure heart rate response (BRS).

Related Experiment Videos

  • Analysis of autonomic markers in patients post-myocardial infarction (ATRAMI trial).
  • Comparison of BRS with established markers like left ventricular ejection fraction and arrhythmias.

    • Main Results:

    • Depressed BRS (< 3 ms/mmHg) is a strong predictor of cardiac mortality.
    • Autonomic marker analysis provides additional prognostic information beyond traditional measures.
    • Combined BRS and ejection fraction depression identifies high-risk patients <65 years.

    Conclusions:

    • Baroreflex sensitivity is a crucial independent risk factor for cardiac death after myocardial infarction.
    • Integrating autonomic assessment enhances risk stratification for sudden cardiac death.
    • Implantable defibrillators may be beneficial for high-risk patients identified by BRS and LVEF analysis.